Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q2 FY26 results · Jul–Sep 2025
Acutaas Chemicals reported revenue from operations of ₹306.20 crore (up 24.1% from Q2 FY25) and net profit of ₹71.86 crore (up 91.3% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 306.20 | 246.73 | +24.1% | 207.24 | +47.8% |
| Other income | 9.84 | 8.44 | +16.6% | 15.94 | −38.3% |
| Total income | 316.03 | 255.17 | +23.9% | 223.17 | +41.6% |
| Profit before tax | 96.18 | 50.04 | +92.2% | 58.08 | +65.6% |
| Net profit for the period | 71.86 | 37.57 | +91.3% | 44.01 | +63.3% |
| Attributable to shareholders of the company | 72.24 | 37.33 | +93.5% | 44.29 | +63.1% |
| EPS, basic (₹) | 8.82 | 9.38 | not comparable | 5.41 | +63.0% |
| Net margin (%) | 23.5 | 15.2 | 21.2 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 305.19 | 243.59 | +25.3% | 205.97 | +48.2% |
| Other income | 8.97 | 8.58 | +4.6% | 16.02 | −44.0% |
| Total income | 314.16 | 252.17 | +24.6% | 221.99 | +41.5% |
| Profit before tax | 97.28 | 50.02 | +94.5% | 58.93 | +65.1% |
| Net profit for the period | 72.89 | 37.68 | +93.5% | 44.65 | +63.3% |
| EPS, basic (₹) | 8.90 | 9.41 | not comparable | 5.45 | +63.3% |
| Net margin (%) | 23.9 | 15.5 | 21.7 |
Consolidated
- Filed with BSE
- 17 Oct 2025, 19:00 IST
- Board meeting
- 17 Oct 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 17 Oct 2025, 19:00 IST
- Board meeting
- 17 Oct 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE